UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer

British journal of cancer, 2013-08, Vol.109 (4), p.920-925

2013

Volltextzugriff (PDF)

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates

Annals of oncology, 2013-07, Vol.24 (7), p.1900-1907

2013

Volltextzugriff (PDF)

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

British journal of cancer, 2013-10, Vol.109 (7), p.1725-1734

2013

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)

Annals of oncology, 2020-01, Vol.31 (1), p.79-87

2020

Volltextzugriff (PDF)

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

British journal of cancer, 2005-07, Vol.93 (2), p.195-199

2005

Volltextzugriff (PDF)

Cavitary Pulmonary Lesions in Patients Infected with Human Immunodeficiency Virus

Clinical infectious diseases, 1996-04, Vol.22 (4), p.671-682

1996

Volltextzugriff (PDF)

CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer

Annals of oncology, 2018-10, Vol.29, p.viii720-viii720

2018

Volltextzugriff (PDF)

A phase I trial of the combination of temsirolimus (TEM) and sorafenib (SOR) in advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS213-TPS213

2010

Volltextzugriff (PDF)

Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan

International Journal of Nanomedicine, 2016-01, Vol.11 (default), p.1225-1235

Ko, Andrew H

2016

Volltextzugriff (PDF)

Community level exposure to chemicals and oxidative stress in adult population

Toxicology letters, 2009-01, Vol.184 (2), p.139-144

2009

Volltextzugriff (PDF)

Corrigendum to ‘Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)’: Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79–87

Annals of oncology, 2020-08, Vol.31 (8), p.1094-1094

2020

Volltextzugriff (PDF)

Hedgehog signaling in gastrointestinal development and disease

Current molecular medicine, 2002-02, Vol.2 (1), p.67-82

2002

Volltextzugriff (PDF)

Acinetobacter species isolates from a range of environments: species survey and observations of antimicrobial resistance

Diagnostic microbiology and infectious disease, 2012-10, Vol.74 (2), p.177-180

2012

Volltextzugriff (PDF)

LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Green tea consumption and risk of stomach cancer: A meta‐analysis of epidemiologic studies

International journal of cancer, 2009-02, Vol.124 (3), p.670-677

2009

Volltextzugriff (PDF)

Non-Hodgkin's lymphoma and Kaposi's sarcoma causing cavitary lung lesions in a patient with AIDS: an HIV-associated collision tumor

AIDS (London), 1995-10, Vol.9 (10), p.1195-1196

1995

Volltextzugriff (PDF)

Kinetic characterization of a prestart cell division control step in yeast. Implications for the mechanism of alpha-factor-induced division arrest

The Journal of biological chemistry, 1990-12, Vol.265 (35), p.21652-21663

1990

Volltextzugriff (PDF)

Acinetobacter sp. isolates from emergency departments in two hospitals of South Korea

Journal of medical microbiology, 2014-10, Vol.63 (10), p.1363-1368

2014

Volltextzugriff (PDF)

Clinical Outcomes Associated with very Late Relapses in Diffuse Large Cell Lymphoma

Leukemia & lymphoma, 2002, Vol.43 (9), p.1789-1793

2002

Volltextzugriff (PDF)

Enzyme replacement therapy improves joint motion and outcome of the 12‐min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation

American journal of medical genetics. Part A, 2012-05, Vol.158A (5), p.1158-1163

2012

Volltextzugriff (PDF)

A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.237-237

2011

Volltextzugriff (PDF)

Clinical and pharmacodynamic (PD) results of TEL0805 trial: A phase II study of telatinib (TEL) in combination with capecitabine (X) and cisplatin (P) as first-line treatment in patients (pts) with advanced gastric or gastroesophageal junction (GEJ) cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4122-4122

2011

Volltextzugriff (PDF)

Biliary stent complications in clinical trials for advanced pancreatic cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14665-e14665

2011

Volltextzugriff (PDF)

A multinational phase II study of PEP02 (liposome irinotecan) for patients with gemcitabine-refractory metastatic pancreatic cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4069-4069

2011

Volltextzugriff (PDF)

Phase I trial of temsirolimus (TEM) plus sorafenib (SOR) in advanced hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.296-296

2011

Volltextzugriff (PDF)

1 – 25 von 23.031

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19.570)
Mit Volltextzugriff
(19.226)

Publikationsform

Artikel
(21.157)
Tagungsberichte
(1.410)
Buchkapitel
(271)
Bücher
(65)
Berichte
(64)
magazinearticle
(38)
Reviews
(14)
Dissertationen
(11)
Texte
(1)

4 weitere anzeigen...

Weniger anzeigen...

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(16.224)
Life Sciences & Biomedicine
(9.852)
Humans
(6.530)
Biological And Medical Sciences
(4.308)
Physical Sciences
(4.226)
Male
(4.224)
Female
(4.097)
Technology
(4.078)
Animals
(3.150)
Medical Sciences
(3.120)
Physics
(2.624)
Middle Aged
(2.469)
Adult
(2.468)
Exact Sciences And Technology
(2.238)
Engineering
(2.061)
Aged
(1.796)
Fundamental And Applied Biological Sciences. Psychology
(1.470)
Chemistry
(1.414)
Materials Science
(1.385)
Mice
(1.366)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(9.694)
MEDLINE
(9.605)
Free E-Journal (出版社公開部分のみ）
(8.235)
Journals@Ovid Full Text
(5.812)
Elsevier ScienceDirect Journals Complete
(5.129)
NUS Single-Journal Subscriptions
(4.352)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(3.499)
IngentaConnect Journals
(3.224)
Wiley-Blackwell Journals
(2.968)
Wiley Online Library Full Collection 2018
(2.148)
SpringerLink Journals - AutoHoldings
(1.780)
IEEE Xplore
(1.658)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.242)
Oxford Journals
(908)
Taylor & Francis Journals Auto-Holdings Collection
(699)
American Physical Society
(690)
APS_美国物理学会过刊
(612)
Taylor & Francis
(577)
Scitation (American Institute of Physics)
(527)
Oxford Journals 2020 Medicine
(526)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

Cavitary Pulmonary Lesions in Patients Infected with Human Immunodeficiency Virus

CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer

A phase I trial of the combination of temsirolimus (TEM) and sorafenib (SOR) in advanced hepatocellular carcinoma (HCC)

Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan

Community level exposure to chemicals and oxidative stress in adult population

Corrigendum to ‘Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)’: Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79–87

Hedgehog signaling in gastrointestinal development and disease

Acinetobacter species isolates from a range of environments: species survey and observations of antimicrobial resistance

LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer

Green tea consumption and risk of stomach cancer: A meta‐analysis of epidemiologic studies

Non-Hodgkin's lymphoma and Kaposi's sarcoma causing cavitary lung lesions in a patient with AIDS: an HIV-associated collision tumor

Kinetic characterization of a prestart cell division control step in yeast. Implications for the mechanism of alpha-factor-induced division arrest

Acinetobacter sp. isolates from emergency departments in two hospitals of South Korea

Clinical Outcomes Associated with very Late Relapses in Diffuse Large Cell Lymphoma

Enzyme replacement therapy improves joint motion and outcome of the 12‐min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation

A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer

Clinical and pharmacodynamic (PD) results of TEL0805 trial: A phase II study of telatinib (TEL) in combination with capecitabine (X) and cisplatin (P) as first-line treatment in patients (pts) with advanced gastric or gastroesophageal junction (GEJ) cancer

Biliary stent complications in clinical trials for advanced pancreatic cancer

A multinational phase II study of PEP02 (liposome irinotecan) for patients with gemcitabine-refractory metastatic pancreatic cancer

Phase I trial of temsirolimus (TEM) plus sorafenib (SOR) in advanced hepatocellular carcinoma (HCC)

Suchergebnisse filtern